dalteparin has been researched along with Alloxan Diabetes in 7 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Socha, M | 1 |
| Bartecki, P | 1 |
| Passirani, C | 1 |
| Sapin, A | 1 |
| Damgé, C | 1 |
| Lecompte, T | 1 |
| Barré, J | 1 |
| El Ghazouani, F | 1 |
| Maincent, P | 1 |
| Artico, M | 1 |
| Massa, R | 1 |
| Cavallotti, D | 1 |
| Franchitto, S | 1 |
| Cavallotti, C | 1 |
| Asselot-Chapel, C | 1 |
| Borchiellini, C | 1 |
| Labat-Robert, J | 1 |
| Kern, P | 1 |
| Cifuentes, A | 1 |
| Gómez-Gil, V | 1 |
| Ortega, MA | 1 |
| Asúnsolo, Á | 1 |
| Coca, S | 1 |
| Román, JS | 1 |
| Álvarez-Mon, M | 1 |
| Buján, J | 1 |
| García-Honduvilla, N | 1 |
| Georgescu, A | 2 |
| Alexandru, N | 1 |
| Nemecz, M | 1 |
| Titorencu, I | 1 |
| Popov, D | 2 |
| Capraru, M | 1 |
| Simionescu, M | 1 |
| Sumi, Y | 1 |
| Ishihara, M | 1 |
| Kishimoto, S | 1 |
| Takikawa, M | 2 |
| Hattori, H | 1 |
| Azuma, R | 1 |
| Nakamura, S | 1 |
| Fujita, M | 1 |
| Kiyosawa, T | 1 |
7 other studies available for dalteparin and Alloxan Diabetes
| Article | Year |
|---|---|
Stealth nanoparticles coated with heparin as peptide or protein carriers.
Topics: Acrylic Resins; Animals; Diabetes Mellitus, Experimental; Drug Carriers; Half-Life; Hypoglycemic Age | 2009 |
Morphological changes in the sciatic nerve of diabetic rats treated with low molecular weight heparin OP 2123/parnaparin.
Topics: Animals; Anticoagulants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiop | 2002 |
Expression of laminin and type IV collagen by basement membrane-producing EHS tumors in streptozotocin-induced diabetic mice: in vivo modulation by low-molecular-weight heparin fragments.
Topics: Animals; Basement Membrane; Collagen; Diabetes Mellitus, Experimental; Heparin, Low-Molecular-Weight | 1996 |
Chitosan hydrogels functionalized with either unfractionated heparin or bemiparin improve diabetic wound healing.
Topics: Animals; Bandages, Hydrocolloid; Chitosan; Collagen Type I; Collagen Type III; Diabetes Mellitus, Ex | 2020 |
Enoxaparin reduces adrenergic contraction of resistance arterioles in aging and in aging associated with diabetes via engagement of MAP kinase pathway.
Topics: Adrenergic Agents; Aging; Animals; Arterioles; Cricetinae; Diabetes Mellitus, Experimental; Diabetes | 2011 |
Enoxaparin--a low molecular weight heparin, restores the altered vascular reactivity of resistance arteries in aged and aged-diabetic hamsters.
Topics: Acetylcholine; Age Factors; Animals; Anticoagulants; Blood Glucose; Cholesterol; Cricetinae; Diabete | 2003 |
Effective wound healing in streptozotocin-induced diabetic rats by adipose-derived stromal cell transplantation in plasma-gel containing fragmin/protamine microparticles.
Topics: Adipose Tissue; Animals; Culture Media; Dalteparin; Diabetes Mellitus, Experimental; Gels; Male; Mul | 2014 |